Nurse-Reported Outcomes of Cannabidiol (CBD) Treatment in the Long-Term Care (LTC) Setting: Results From the BEhavior, COgnition, and More With Epidiolex® in the Long-Term Care Setting (BECOME-LTC) Survey (P2-9.016)
The BECOME-LTC survey evaluated nurses’ perspectives of changes in seizure frequency and nonseizure outcomes (communication, cognition, sleep, emotional and physical functioning) after CBD initiation in LTC residents with epilepsy.
Authors
- Sheila Μ. Thomas (ORCID: https://orcid.org/0000-0003-3327-0528)
- A. C. Fowler (ORCID: https://orcid.org/0000-0002-2062-6372)
- Jason T. Shafrin (ORCID: https://orcid.org/0000-0001-8444-5979)
- Allan Chung (ORCID: https://orcid.org/0009-0004-5244-1534)
- Karthik Rajasekaran (ORCID: https://orcid.org/0000-0003-2148-1643)
- Suhail Thahir
- Nanette Wrobel
Institutions
- Jazz Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212295
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00